USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
24-Feb-2016
Global
Technology Research
D6D1-01-00-00-00
HC02621-SA-TR_16743
Over the past decade, global industry leaders offering neuromodulation technologies have been largely successful in implementing large scale value stream transformation programs in setting a mature cost-to-serve model. However, understanding the gaps between OEM initiatives in delivering value to care payers and payer demands have been limited. This research service offers a strategic perspective on the industry, analyzing the gaps between technology push-pull factors that are poised to enable OEMs sustain both volume growth and margin. This research also examines how OEMs can shift from a value-to-cost model to a value-to-serve business model, which plays a lead role in delivering personalized value to healthcare payers and care providers.
1.1 Scope of Research
1.2 Research Methodology
2.1 Transferring Cost Efficiencies across the Value Chain
2.2 IP Filings Focus on Minimally Invasive Therapies
2.3 Clinical Trials to Diversify Product Pipeline
2.4 Differentiate Products by Building a Value-driven Organization
3.1 Invasive, Minimally Invasive and Non-Invasive Neuromodulation Technologies
3.2 High Market Demand for Non-Invasive Methods and Therapies for Lifestyle Disorders
3.3 Spinal Cord and Deep Brain Stimulation Systems, Global, 2016
3.4 Vagus Nerve and Other Stimulation Systems, Global, 2016
3.5 NPD Efforts Focus on Miniaturization of Implants
3.6 Objectives of OEMs Are Aligned to Delivering Personalized Value to Payers
3.7 Focus on Creating Effective Collaboration among Payers Drive Channel Growth
3.8 Neuromodulation Systems, Prices, Global, 2016
3.9 Assessment of Components of Neuromodulation Systems
3.10 Analytical Hierarchy Process: Prioritization of Neuromodulation Technologies
3.11 Performance of Pulse Generator and Lead Precision Is of High Priority
3.12 Functionality of Device Controller and Programmer Are of Least Priority
3.13 Improving the Longevity of Power Supplies and Lead Flexibility
3.14 Payer Preference to Minimally Invasive Therapies for Chronic Conditions
4.1 80% of Market Share Is Owned by Four Companies
4.2 Cost-efficient Value Chain and Consolidation Efforts Drive Profitable Growth
4.3 Better Patient-Physician Collaboration Drive Technology Growth
4.4 Consolidation Trends Pull Prospective Investments within the Global Industry
4.5 OEMs Race against VC/PE Firms to Invest in Neuromodulation Technologies
4.6 Increase in Cross-selling Agreements with Pharmaceutical Companies
4.7 OEMs Place a Premium during Commercialization of Co-created Products
4.8 Established Mid-size Firms Are Partnership Targets in Emerging Markets
4.9 Backward Integration Efforts of OEMs Will Deliver Personalized Value
4.10 VC and Major Pharmaceutical Firms Influence Growth in Delivery of Quality Care
5.1 Centricity between Cost Efficiency and Market Maturity Enabled Customer Value
5.2 Neuromodulation: Key Growth Strategies for a Value-Driven Business Model, Global, 2016
5.3 Value-for-Cost Business Model: OEMs Focus on Cost Savings within the Value-Chain
6.1 A Robust Operations Analytics Framework to Drive Quality Patient Care
6.2 Strategic Partnerships Deliver Sustainable Growth and Value Proposition
7.1 Boston Scientific Leads in IP Creation Activities Worldwide
7.2 Key Patents: Cantilever Electrodes for Transdermal and Transcranial Stimulation
7.3 Key Patents: Optogenetic Therapies for Movement Disorders
7.4 Key Patents: Minimally Invasive Implantable Neurostimulation Systems
7.5 List of Key Industry Participants
Legal Disclaimer
8.1 Analytical Hierarchical Process
8.2 Explanation of Benchmarking Criteria
8.3 Liberatore’s Rating Scale
9.1 The Frost & Sullivan Story
9.2 Value Proposition: Future of Your Company & Career
9.3 Global Perspective
9.4 Industry Convergence
9.5 360º Research Perspective
9.6 Implementation Excellence
9.7 Our Blue Ocean Strategy
Speak directly with our analytics experts for tailored recommendations.
Recent related Technology and IP research
09 May 2016 | Global | Technology Research
Emerging Applications of Nanocellulose Technology
The nanocellulose market has the potential to span many different industries that can be categorized as high volume and low volume applications. In order to be successful in nanocellulose business there must be a consistent supply of material that can be delivered in a cost-effective manner for the...
04 May 2016 | Global | Technology Research
Advanced Insulation Materials Technologies for Building and Construction
Global insulation materials industry is poised for growth due to the rising demand of efficient insulation in both residential sector on account of the increase in energy costs and tightening governmental policies. The importance of energy conservation is also expected to drive the insulation marke...
30 Mar 2016 | Global | Technology Research
Next Generation Diabetes Therapy and Drug Delivery Technologies
Diabetes has exhibited dramatic increases during the past decade, registering a global prevalence of 9% among adults aged 18 years and older, and is projected to be the 7th-leading cause of death by 2030. The most popular treatment for type 1 diabetes mellitus (T1DM) is multiple daily insulin (MDI) ...
30 Mar 2016 | North America | Technology Research
Enabling Technologies in Global Surgical Robots Market
Robots have increasingly become important in the field of surgical interventions due to growing complexity of surgical procedures for difficult diseases, and greater demand towards minimal invasive surgery. This research service highlights technological advances and innovations in surgical robots. T...
30 Mar 2016 | Global | Technology Research
Next Generation Stent Technologies
The coronary stent market is in the midst of tremendous change. The declining popularity of bare-metal stents have opened up opportunities for the next generation of stents to occupy the market share. This research service identifies possible areas of innovation available for stent companies to leve...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Technology Research |
|---|---|
| No Index | No |
| Podcast | No |
| WIP Number | D6D1-01-00-00-00 |
| Is Prebook | No |
Neuromodulation Technologies - A Strategic Perspective (TechVision)
$4,950.00
Special Price $3,712.50 save 25 %